In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Anticancer Research

• Publication date

  2005-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 16158930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell Cycle–Dependent Antagonistic Interactions between Paclitaxel and γ-Radiation in Combination Therapy

  2004cited by this paper
• Reversal of MDR by Verapamil Analogues

  2004cited by this paper
• P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement.

  2003cited by this paper
• The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.

  2002cited by this paper
• Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids.

  2001cited by this paper
• Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action.

  2001cited by this paper
• In Vitro and in Vivo Reversal of P-Glycoprotein-mediated Multidrug Resistance by a Novel Potent Modulator , XR 9576

  2001cited by this paper
• In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.

  2001cited by this paper
• Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.

  2000cited by this paper
• In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells.

  2000cited by this paper
• Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.

  2000cited by this paper
• Reversal of multidrug resistance of tumor cells.

  2000cited by this paper
• Nuclear Factor-κB/IκB Signaling Pathway May Contribute to the Mediation of Paclitaxel-induced Apoptosis in Solid Tumor Cells

  2000cited by this paper
• PSC833, cyclosporin A, and dexniguldipine effects on cellular calcein retention and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.

  1999cited by this paper
• Multidrug resistance in oncology: diagnostic and therapeutic approaches

  1999cited by this paper
• Possible mechanisms of paclitaxel-induced apoptosis.

  1999cited by this paper
• Antagonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy.

  1999cited by this paper
• Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.

  1999cited by this paper
• P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.

  1999cited by this paper
• Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors

  1998cited by this paper
• The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?

  1998cited by this paper
• Avoidance of doxorubicin resistance in osteosarcoma cells using a new quinoline derivative, MS-209.

  1998cited by this paper
• PSC-833, a frontier in modulation of P-glycoprotein mediated multidrug resistance

  1998cited by this paper
• Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.

  1998cited by this paper
• Pharmacologic approaches to reversing multidrug resistance.

  1997cited by this paper
• Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.

  1997cited by this paper
• Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.

  1997cited by this paper
• The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?

  1997cited by this paper
• Multidrug resistance: molecular mechanisms and clinical relevance

  1997cited by this paper
• Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers.

  1996cited by this paper
• Clinical trials of P-glycoprotein reversal in solid tumours.

  1996cited by this paper
• Inactivation of Bcl-2 by phosphorylation.

  1995cited by this paper
• Functional modulation of multidrug resistance-related P-glycoprotein by Ca(2+)-calmodulin

  1995cited by this paper
• [Vincristine-resistant human KB cell line and mechanism of multidrug resistance].

  1994cited by this paper
• Cell biological mechanisms of multidrug resistance in tumors.

  1994cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

  1993cited by this paper
• A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

  1991cited by this paper

• Critical review and future perspectives on the anticancer effects of Stephania tetrandra S. Moore

  2025cites this paper
• Insights on exploring the therapeutic potential and structural modification of Tetrandrine.

  2024cites this paper
• Comparative Evaluation of the Anti-proliferative Effects of Alkaloid-Rich Extract of Jujube Seed and Paclitaxel on MDA-MB-231 Breast Cancer Cell Line

  2024cites this paper
• In Silico and In Vitro Identification of P-Glycoprotein Inhibitors from a Library of 375 Phytochemicals

  2023cites this paper
• Targeting the two-pore channel 2 in cancer progression and metastasis

  2022cites this paper
• A Worldwide Bibliometric Analysis of Tetrandrine Research in Recent Two Decades

  2022cites this paper
• Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects

  2021cites this paper
• All-in-one Nanosponge with Pluronic Shell for synergistic anticancer therapy through effectively overcoming multidrug resistance in Cancer.

  2021cites this paper
• Pharmacotherapeutic Botanicals for Cancer Chemoprevention

  2020cites this paper
• Natural Products as Chemosensitizers for Adjunct Therapy in Cancer Management

  2020cites this paper
• Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems

  2020cites this paper
• Interactions between artemisinin derivatives and P-glycoprotein.

  2019cites this paper
• Medicinal Plants as a Source of Alkaloids

  2019cites this paper
• Reversal of P-Glycoprotein and Breast Cancer Resistance Protein Mediated Multidrug Resistance In Vitro Using In Silico Identified Novel Compounds

  2019cites this paper
• Naturally Derived Formulations and Prospects towards Cancer

  2019cites this paper
• Application of alkaloids in reversing multidrug resistance in human cancers.

  2018cites this paper
• Tetrandrine and cancer – An overview on the molecular approach

  2018cites this paper
• Tetrandrine and cancer - An overview on the molecular approach.

  2018cites this paper
• Effect of five novel 5-substituted tetrandrine derivatives on P-glycoprotein-mediated inhibition and transport in Caco-2 cells.

  2018cites this paper
• Reversal of P-glycoprotein-mediated multidrug resistance and pharmacokinetics study in rats by WYX-5.

  2017cites this paper
• Determination of a novel anticancer AMPK activator hernandezine in rat plasma and tissues with a validated UHPLC–MS/MS method: Application to pharmacokinetics and tissue distribution study

  2017cites this paper
• Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer.

  2017cites this paper
• Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells

  2017cites this paper
• Tetrandrine potentiates the glucocorticoid pharmacodynamics via inhibiting P‐glycoprotein and mitogen‐activated protein kinase in mitogen‐activated human peripheral blood mononuclear cells

  2017cites this paper
• Superior antitumor effect of extremely high drug loading self-assembled paclitaxel nanofibers.

  2017cites this paper
• Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.

  2017cites this paper
• NVP‐TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P‐glycoprotein (PGP1) function

  2016cites this paper
• Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression

  2016cites this paper
• Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy

  2016cites this paper
• Pharmacokinetic herb–drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research

  2016cites this paper
• Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1.

  2016cites this paper
• P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design.

  2016cites this paper
• The development of a quantitative and qualitative method based on UHPLC-QTOF MS/MS for evaluation paclitaxel-tetrandrine interaction and its application to a pharmacokinetic study.

  2016cites this paper
• Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance.

  2015cites this paper
• Synthesis, crystal structures and phase transformation of the new solid-state forms of tetrandrine

  2014cites this paper
• Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells

  2014cites this paper
• AB228. Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells

  2014cites this paper
• Overcoming of P-glycoprotein-mediated multidrug resistance of tumors in vivo by drug combinations

  2014cites this paper
• INHIBITORY EFFECT OF TETRANDRINE AND PACLITAXEL OR DOXORUBICIN ON MULTI-DRUG-RESISTANT (MDR) CANCER CELLS ASSOCIATED WITH MDR-ATPASE

  2014cites this paper
• Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cells.

  2013cites this paper
• Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function.

  2013cites this paper
• Tetrandrine exerts antidepressant-like effects in animal models: role of brain-derived neurotrophic factor.

  2013cites this paper
• Tetrandrine Induces Mitochondria-Mediated Apoptosis in Human Gastric Cancer BGC-823 Cells

  2013cites this paper
• Cellular Redox Status Regulates Emodin-Induced Radiosensitization of Nasopharyngeal Carcinoma Cells In Vitro and In Vivo

  2013cites this paper
• Dexamethasone inhibits the effect of paclitaxel on human ovarian carcinoma xenografts in nude mice.

  2013cites this paper
• Targeted acid-labile conjugates of norcantharidin for cancer chemotherapy

  2012cites this paper
• Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents

  2012cites this paper
• Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer

  2012cites this paper
• Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes.

  2012cites this paper
• Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors

  2012cites this paper
• Alkaloids Isolated from Natural Herbs as the Anticancer Agents

  2012cites this paper
• Three decades of P-gp inhibitors: skimming through several generations and scaffolds.

  2012cites this paper
• Plant Compounds and Derivatives as Inhibitors of Cancer Cell Multidrug Resistance

  2011cites this paper
• Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo.

  2011cites this paper
• The role of technetium‐99m methoxyisobutyl isonitrile scintigraphy in predicting the therapeutic effect of chemotherapy against nasopharyngeal carcinoma

  2011cites this paper
• Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription

  2010cites this paper
• The Potential of Tetrandrine against Gliomas.

  2010cites this paper
• Multidrug Resistance Reversal Agent, NSC77037, Identified with a Cell-Based Screening Assay

  2010cites this paper
• Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer

  2010cites this paper
• NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance

  2009cites this paper
• Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of β-tubulin at Cys 12 and suppression of microtubule dynamics

  2009cites this paper
• Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells

  2008cites this paper
• [Inhibitory effect of tetrandrine on angiogenesis].

  2008cites this paper
• Reversal in multidrug resistance by magnetic nanoparticle of Fe 3 O 4 loaded with adriamycin and tetrandrine in K 562 / A 02 leukemic cells

  2008cites this paper
• Molecular modes of action of cytotoxic alkaloids: from DNA intercalation, spindle poisoning, topoisomerase inhibition to apoptosis and multiple drug resistance.

  2007cites this paper
• The Phenotypically Suppressed Cancer Cell As a Therapeutic Target

  2006cites this paper
• Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors

  2006cites this paper
• Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Daunorubicin-loaded Magnetic Nanoparticles of Fe 3 O 4 Overcome Multidrug Resistance and Induce Apoptosis of K562-n/vcr Cells in Vivo Jia-hua Ding

  year unknowncites this paper